P

Inventor

CHERNEY ROBERT J

US34 patents
⚠️ This page may combine multiple inventors who share the name “CHERNEY ROBERT J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BRISTOL MYERS SQUIBB CO

23 patents
US7183270B2Feb 27, 2007

Cyclic derivatives as modulators of chemokine receptor activity

BRISTOL MYERS SQUIBB CO52 citations96
US7163937B2Jan 16, 2007

Cyclic derivatives as modulators of chemokine receptor activity

BRISTOL MYERS SQUIBB CO29 citations92
US7087604B2Aug 8, 2006

Cyclic derivatives as modulators of chemokine receptor activity

BRISTOL MYERS SQUIBB CO23 citations92
US10273259B2Apr 30, 2019

Tricyclic sulfones as RORγ modulators

BRISTOL MYERS SQUIBB CO4 citations84
US8383812B2Feb 26, 2013

N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-3-(7-tert-butylpyrazolo[1,5-A][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a dual modulator of chemokine receptor activity, crystalline forms and processes

BRISTOL MYERS SQUIBB CO9 citations84
US7378409B2May 27, 2008

Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity

BRISTOL MYERS SQUIBB CO20 citations83
US9815859B2Nov 14, 2017

Tricyclic sulfones as RORγ modulators

BRISTOL MYERS SQUIBB CO11 citations82
US7338947B2Mar 4, 2008

Cyclic derivatives as modulators of chemokine receptor activity

BRISTOL MYERS SQUIBB CO6 citations74
US7291615B2Nov 6, 2007

Cyclic derivatives as modulators of chemokine receptor activity

BRISTOL MYERS SQUIBB CO7 citations74
US7482335B2Jan 27, 2009

Cyclic derivatives as modulators of chemokine receptor activity

BRISTOL MYERS SQUIBB CO6 citations73
US11524959B1Dec 13, 2022

Indole and azaindole inhibitors of pad enzymes

BRISTOL MYERS SQUIBB CO3 citations72
US10023576B2Jul 17, 2018

Heteroaryl substituted pyrrolotriazine amine compounds as PI3K inhibitors

BRISTOL MYERS SQUIBB CO2 citations72
US8618101B2Dec 31, 2013

N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-3-(7-tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a dual modulator of chemokine receptor activity, crystalline forms and processes

BRISTOL MYERS SQUIBB CO2 citations63
US7671062B2Mar 2, 2010

Modulators of chemokine receptor activity, crystalline forms and process

BRISTOL MYERS SQUIBB CO4 citations63
US10711020B2Jul 14, 2020

Tricyclic sulfones as RORγ modulators

BRISTOL MYERS SQUIBB CO0 citations52
US8906920B2Dec 9, 2014

N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-3-(7-tert-butylpyrazolo[1,5-A][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a dual modulator of chemokine receptor activity, crystalline forms and processes

BRISTOL MYERS SQUIBB CO0 citations52
US7829571B2Nov 9, 2010

Cyclic derivatives as modulators of chemokine receptor activity

BRISTOL MYERS SQUIBB CO0 citations52
US7776884B2Aug 17, 2010

Cyclic derivatives as modulators of chemokine receptors activity

BRISTOL MYERS SQUIBB CO0 citations52
US7696205B2Apr 13, 2010

Cyclic derivatives as modulators of chemokine receptor activity

BRISTOL MYERS SQUIBB CO0 citations52
US7687508B2Mar 30, 2010

Cyclic derivatives as modulators of chemokine receptor activity

BRISTOL MYERS SQUIBB CO0 citations52
US10934286B2Mar 2, 2021

Heterocyclic sulfones as ROR gamma modulators

BRISTOL MYERS SQUIBB CO0 citations51
US12473304B2Nov 18, 2025

Heterocyclic PAD4 inhibitors

BRISTOL MYERS SQUIBB CO0 citations43
US10214537B2Feb 26, 2019

Bicyclic heteroaryl amine compounds

BRISTOL MYERS SQUIBB CO0 citations41

DU PONT MERCK PHARMA

4 patents

CHERNEY ROBERT J

3 patents

BRISTOL MYERS SQUIBB PHARMA CO

2 patents

DU PONT PHARM CO

1 patent

DHAR T G MURALI

1 patent